This company seems to have been delisted
Reason: Acquired by Amgen
Last recorded trade on: November 25, 2022
Source: https://www.amgen.com/newsroom/press-releases/2022/08/amgen-to-acquire-chemocentryx-for-$4-billion-in-cash
Reason: Acquired by Amgen
Last recorded trade on: November 25, 2022
Source: https://www.amgen.com/newsroom/press-releases/2022/08/amgen-to-acquire-chemocentryx-for-$4-billion-in-cash
ChemoCentryx
CCXI
£40.07
Share price
0.00%
Change (1 day)
30.66%
Change (1 year)
Categories
EPS for ChemoCentryx (CCXI)
EPS in 2022 (TTM): -£1.45
According to ChemoCentryx's latest financial reports the company's current EPS (TTM) is -£1.46. In 2021 the company made an earnings per share (EPS) of -£1.46 a decrease over its 2020 EPS that were of -£0.62.
EPS history for ChemoCentryx from 2012 to 2022
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2022 (TTM) | -£1.45 | -0.5% |
| 2021 | -£1.46 | 133.33% |
| 2020 | -£0.62 | -16.49% |
| 2019 | -£0.75 | 27.63% |
| 2018 | -£0.59 | -305.41% |
| 2017 | £0.29 | -142.53% |
| 2016 | -£0.67 | -19.44% |
| 2015 | -£0.83 | -0% |
| 2014 | -£0.83 | 13.68% |
| 2013 | -£0.73 | -16.67% |
| 2012 | -£0.88 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | £14.23 | -1,076.72% | 🇺🇸 USA |
 | £2.84 | -294.74% | 🇺🇸 USA |
 | £2.70 | -285.22% | 🇬🇧 UK |
 | £3.06 | -310.05% | 🇺🇸 USA |
 | £10.86 | -845.25% | 🇺🇸 USA |
 | £10.91 | -848.68% | 🇺🇸 USA |
 | £1.43 | -198.41% | 🇺🇸 USA |
 | -£1.54 | 5.82% | 🇮🇱 Israel |
 | £1.40 | -196.39% | 🇺🇸 USA |